News from the healthcare data industry
Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next generation commercial services to the global life...
Foundation Medicine’s tissue-based test is the first and only comprehensive genomic profiling test to be approved as a companion diagnostic for a third group of targeted therapies March 17, 2022...
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
MIAMI—Google Health is expanding the capabilities of its clinician-facing search tool using artificial intelligence to bring context to physicians’ clinical notes. Speaking at the ViVE 2022 conference, Paul Muret, vice president and...
AI-driven discovery platform enables new way to find novel pathways as well as progress towards identifying patients who may better respond to drugs in the clinic Preclinical data highlights the...
TUESDAY MARCH 8TH, 2022 Those without boosters nearly two times more likely to get COVID-19 during Omicron surge, with greater risk for those with co-morbidities BELLEVUE, Wash.– March 8, 2022...
New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes.xCures and BioSpark are driving a fundamental shift in the quality, utility, and value...
First-of-its-kind data module is now available for analysis through Verana Health’s real-world evidence service offerings to help life sciences organizations shape glaucoma therapeutic strategies Mar 02, 2022, 10:00 ET SAN...
March 01, 2022 12:34 ET | Source: Health Gorilla Palo Alto, California, March 01, 2022 (GLOBE NEWSWIRE) — Health Gorilla, the leading Health Information Network in the United States, announces they will begin...
Foundation Medicine’s tissue-based comprehensive genomic profiling test is now the first and only FDA-approved companion diagnostic to aid in identifying patients with MSI-H solid tumors who may benefit from immunotherapy...